In a statement Novartis AG said, it has launched a new share buyback of up to $15 billion which will end by 2023. Confirming an expected sales growth by 4% through 2026, the Swiss pharma giant said its capital allocation strategy… Read More ›
excess capital
Hyundai Motor Co to spend $228.3 million for repurchase of shares
The Elliot Management-backed move, will boost shareholder’s return. The buyback will include common and preferred stocks. On Friday, Hyundai Motor Co stated, it would spend $228.3 million (255 billion won) to buyback its common and preferred stocks so as to… Read More ›